Eli Lilly’s Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts Proactive Investors (US) 21:06 Tue, 21 Apr
Lilly acquires Kelonia Therapeutics for $7 B to advance in vivo CAR-T cell therapies BioSpectrum Asia 12:10 Tue, 21 Apr
Eli Lilly and Co Reportedly Close to $2 Billion Acquisition of Kelonia Therapeutics IBTimes (US) 18:57 Mon, 20 Apr
STAT Plus: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride STAT 17:06 Mon, 20 Apr
Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisition Proactive Investors (US) 16:10 Mon, 20 Apr
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies PR Newswire (Press Release) 14:01 Mon, 20 Apr
